Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-16 Sale | 2022-05-17 9:33 pm | NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer | 4,592 | $3.95 | $18,138 | 223,210 (Direct) | View |
| 2022-02-16 Sale | 2022-02-18 6:15 pm | NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer | 4,852 | $10.95 | $53,129 | 227,802 (Direct) | View |
| 2021-11-16 Sale | 2021-11-17 6:06 pm | NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer | 6,061 | $13.16 | $79,763 | 194,854 (Direct) | View |
| 2021-08-16 Sale | 2021-08-18 6:59 pm | NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer | 6,192 | $13.83 | $85,635 | 200,915 (Direct) | View |
| 2021-05-17 Sale | 2021-05-19 7:04 pm | NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer | 6,085 | $18.3 | $111,356 | 207,107 (Direct) | View |
| 2021-02-16 Sale | 2021-02-18 7:03 pm | NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer | 15,358 | $22.37 | $343,558 | 213,192 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-12-16 Option Award | 2021-12-20 8:24 pm | N/A 2029-12-15 | NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer | 104,950 | $0 | 299,804 (Direct) | View |
| 2020-12-18 Option Award | 2020-12-22 6:49 pm | N/A 2028-12-17 | NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer | 79,550 | $0 | 279,550 (Direct) | View |